Pcn115 a Cross-Country Comparison of Second-Line Multiple Myeloma Treatments

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.02.969
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Cross-Country Comparison of Labor Force Participation

2015English

Individual Attitudes Toward Migrants: A Cross-Country Comparison

China-USA Business Review
2016English

Measuring Labor Market Frictions: A Cross-Country Comparison

Journal of the European Economic Association
EconomicsEconometricsFinance
2003English

Progress in the Front-Line Treatment of Multiple Myeloma

European Oncology and Haematology
OncologyHematology
2010English

Heterogeneity of Second-Line Treatment for Patients With Multiple Myeloma in the Connect ® MM Registry (2010–2016)

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Women’s Entrepreneurship Policy: A 13 Nation Cross-Country Comparison

International Journal of Gender and Entrepreneurship
Gender StudiesEconomicsInternational ManagementBusinessEconometrics
2017English

Evaluation of Public R&D Policies: A Cross-Country Comparison

SSRN Electronic Journal
2010English

Establishment of a Bortezomib-Resistant Chinese Human Multiple Myeloma Cell Line: MMLAL

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib

Seminars in Hematology
Hematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy